Literature DB >> 23472229

Misidentification of putative medullary thyroid cancer cell lines RO-H85-1 and RO-D81-1.

Tikva Dadon1, Douglas Ball, Barry D Nelkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23472229     DOI： 10.1210/jc.2012-4181

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Thyroid cancer cell line misidentification: an update.

Authors:  Rebecca E Schweppe
Journal:  J Clin Endocrinol Metab       Date:  2013-03       Impact factor: 5.958

2.  Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.

Authors:  Matti L Gild; Iñigo Landa; Mabel Ryder; Ronald A Ghossein; Jeffrey A Knauf; James A Fagin
Journal:  Endocr Relat Cancer       Date:  2013-08-21       Impact factor: 5.900

3.  A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.

Authors:  Gianluca Occhi; Susi Barollo; Daniela Regazzo; Loris Bertazza; Francesca Galuppini; Vincenza Guzzardo; Marie Lise Jaffrain-Rea; Federica Vianello; Denis Ciato; Filippo Ceccato; Sara Watutantrige-Fernando; Andrea Bisognin; Stefania Bortoluzzi; Gianmaria Pennelli; Marco Boscaro; Carla Scaroni; Caterina Mian
Journal:  Oncotarget       Date:  2015-10-13

4.  Destabilizing RET in targeted treatment of thyroid cancers.

Authors:  M L Gild; M Bullock; C K Pon; B G Robinson; R J Clifton-Bligh
Journal:  Endocr Connect       Date:  2015-11-16       Impact factor: 3.335

5.  Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer.

Authors:  Caitlin O Caperton; Lee Ann Jolly; Nicole Massoll; Andrew J Bauer; Aime T Franco
Journal:  Cancers (Basel)       Date:  2021-03-04       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.